nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—ABCB1—peripheral nervous system neoplasm	0.24	1	CbGaD
Indinavir—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.0542	0.0963	CbGbCtD
Indinavir—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.0392	0.0697	CbGbCtD
Indinavir—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0359	0.0638	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0359	0.0638	CbGbCtD
Indinavir—ABCC1—Vincristine—peripheral nervous system neoplasm	0.0334	0.0593	CbGbCtD
Indinavir—ABCC1—Etoposide—peripheral nervous system neoplasm	0.0306	0.0543	CbGbCtD
Indinavir—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0269	0.0479	CbGbCtD
Indinavir—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0247	0.0439	CbGbCtD
Indinavir—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.023	0.0409	CbGbCtD
Indinavir—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0226	0.0402	CbGbCtD
Indinavir—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.0209	0.0371	CbGbCtD
Indinavir—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0189	0.0335	CbGbCtD
Indinavir—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0189	0.0335	CbGbCtD
Indinavir—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0181	0.0321	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0165	0.0293	CbGbCtD
Indinavir—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0165	0.0293	CbGbCtD
Indinavir—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0154	0.0274	CbGbCtD
Indinavir—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0131	0.0232	CbGbCtD
Indinavir—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0124	0.022	CbGbCtD
Indinavir—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0113	0.0201	CbGbCtD
Indinavir—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0113	0.0201	CbGbCtD
Indinavir—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0105	0.0187	CbGbCtD
Indinavir—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00805	0.0143	CbGbCtD
Indinavir—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00774	0.0138	CbGbCtD
Indinavir—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00751	0.0133	CbGbCtD
Indinavir—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00738	0.0131	CbGbCtD
Indinavir—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00503	0.00894	CbGbCtD
Indinavir—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00482	0.00857	CbGbCtD
Indinavir—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00474	0.00843	CbGbCtD
Indinavir—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00442	0.00786	CbGbCtD
Indinavir—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00302	0.00536	CbGbCtD
Indinavir—Lopinavir—ABCB1—peripheral nervous system neoplasm	0.00068	0.39	CrCbGaD
Indinavir—Nelfinavir—ABCB1—peripheral nervous system neoplasm	0.000632	0.362	CrCbGaD
Indinavir—Saquinavir—ABCB1—peripheral nervous system neoplasm	0.000433	0.248	CrCbGaD
Indinavir—Nausea—Melphalan—peripheral nervous system neoplasm	9.33e-05	0.000478	CcSEcCtD
Indinavir—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	9.31e-05	0.000477	CcSEcCtD
Indinavir—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	9.23e-05	0.000473	CcSEcCtD
Indinavir—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	9.22e-05	0.000472	CcSEcCtD
Indinavir—Abdominal pain—Vincristine—peripheral nervous system neoplasm	9.19e-05	0.000471	CcSEcCtD
Indinavir—Body temperature increased—Vincristine—peripheral nervous system neoplasm	9.19e-05	0.000471	CcSEcCtD
Indinavir—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	9.16e-05	0.00047	CcSEcCtD
Indinavir—Skin disorder—Etoposide—peripheral nervous system neoplasm	9.15e-05	0.000469	CcSEcCtD
Indinavir—Dry skin—Doxorubicin—peripheral nervous system neoplasm	9.11e-05	0.000467	CcSEcCtD
Indinavir—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	9.1e-05	0.000467	CcSEcCtD
Indinavir—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	9.1e-05	0.000466	CcSEcCtD
Indinavir—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	9.04e-05	0.000463	CcSEcCtD
Indinavir—Anorexia—Etoposide—peripheral nervous system neoplasm	8.97e-05	0.00046	CcSEcCtD
Indinavir—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	8.95e-05	0.000459	CcSEcCtD
Indinavir—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	8.93e-05	0.000458	CcSEcCtD
Indinavir—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	8.9e-05	0.000456	CcSEcCtD
Indinavir—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	8.89e-05	0.000455	CcSEcCtD
Indinavir—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	8.87e-05	0.000455	CcSEcCtD
Indinavir—Gastritis—Doxorubicin—peripheral nervous system neoplasm	8.79e-05	0.000451	CcSEcCtD
Indinavir—Pain—Cisplatin—peripheral nervous system neoplasm	8.79e-05	0.00045	CcSEcCtD
Indinavir—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	8.76e-05	0.000449	CcSEcCtD
Indinavir—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	8.76e-05	0.000449	CcSEcCtD
Indinavir—Dysuria—Epirubicin—peripheral nervous system neoplasm	8.68e-05	0.000445	CcSEcCtD
Indinavir—Asthenia—Alitretinoin—peripheral nervous system neoplasm	8.65e-05	0.000444	CcSEcCtD
Indinavir—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	8.65e-05	0.000443	CcSEcCtD
Indinavir—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	8.63e-05	0.000442	CcSEcCtD
Indinavir—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	8.57e-05	0.000439	CcSEcCtD
Indinavir—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	8.56e-05	0.000439	CcSEcCtD
Indinavir—Pruritus—Alitretinoin—peripheral nervous system neoplasm	8.53e-05	0.000437	CcSEcCtD
Indinavir—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	8.47e-05	0.000434	CcSEcCtD
Indinavir—Paraesthesia—Etoposide—peripheral nervous system neoplasm	8.45e-05	0.000433	CcSEcCtD
Indinavir—Weight increased—Epirubicin—peripheral nervous system neoplasm	8.45e-05	0.000433	CcSEcCtD
Indinavir—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	8.42e-05	0.000432	CcSEcCtD
Indinavir—Dyspnoea—Etoposide—peripheral nervous system neoplasm	8.39e-05	0.00043	CcSEcCtD
Indinavir—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	8.37e-05	0.000429	CcSEcCtD
Indinavir—Somnolence—Etoposide—peripheral nervous system neoplasm	8.37e-05	0.000429	CcSEcCtD
Indinavir—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	8.37e-05	0.000429	CcSEcCtD
Indinavir—Asthenia—Vincristine—peripheral nervous system neoplasm	8.34e-05	0.000427	CcSEcCtD
Indinavir—Pneumonia—Epirubicin—peripheral nervous system neoplasm	8.32e-05	0.000427	CcSEcCtD
Indinavir—Vomiting—Dactinomycin—peripheral nervous system neoplasm	8.27e-05	0.000424	CcSEcCtD
Indinavir—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	8.25e-05	0.000423	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	8.2e-05	0.000421	CcSEcCtD
Indinavir—Rash—Dactinomycin—peripheral nervous system neoplasm	8.2e-05	0.00042	CcSEcCtD
Indinavir—Decreased appetite—Etoposide—peripheral nervous system neoplasm	8.18e-05	0.00042	CcSEcCtD
Indinavir—Renal failure—Epirubicin—peripheral nervous system neoplasm	8.13e-05	0.000417	CcSEcCtD
Indinavir—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	8.13e-05	0.000417	CcSEcCtD
Indinavir—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	8.12e-05	0.000416	CcSEcCtD
Indinavir—Fatigue—Etoposide—peripheral nervous system neoplasm	8.12e-05	0.000416	CcSEcCtD
Indinavir—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	8.11e-05	0.000416	CcSEcCtD
Indinavir—Jaundice—Epirubicin—peripheral nervous system neoplasm	8.07e-05	0.000413	CcSEcCtD
Indinavir—Constipation—Etoposide—peripheral nervous system neoplasm	8.05e-05	0.000413	CcSEcCtD
Indinavir—Pain—Etoposide—peripheral nervous system neoplasm	8.05e-05	0.000413	CcSEcCtD
Indinavir—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	8.04e-05	0.000412	CcSEcCtD
Indinavir—Dysuria—Doxorubicin—peripheral nervous system neoplasm	8.03e-05	0.000412	CcSEcCtD
Indinavir—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	7.98e-05	0.000409	CcSEcCtD
Indinavir—Dizziness—Alitretinoin—peripheral nervous system neoplasm	7.98e-05	0.000409	CcSEcCtD
Indinavir—Diarrhoea—Vincristine—peripheral nervous system neoplasm	7.95e-05	0.000408	CcSEcCtD
Indinavir—Sweating—Epirubicin—peripheral nervous system neoplasm	7.93e-05	0.000407	CcSEcCtD
Indinavir—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	7.93e-05	0.000407	CcSEcCtD
Indinavir—Haematuria—Epirubicin—peripheral nervous system neoplasm	7.89e-05	0.000404	CcSEcCtD
Indinavir—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	7.83e-05	0.000401	CcSEcCtD
Indinavir—Weight increased—Doxorubicin—peripheral nervous system neoplasm	7.82e-05	0.000401	CcSEcCtD
Indinavir—Sinusitis—Epirubicin—peripheral nervous system neoplasm	7.76e-05	0.000398	CcSEcCtD
Indinavir—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	7.76e-05	0.000398	CcSEcCtD
Indinavir—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	7.75e-05	0.000397	CcSEcCtD
Indinavir—Nausea—Dactinomycin—peripheral nervous system neoplasm	7.73e-05	0.000396	CcSEcCtD
Indinavir—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	7.7e-05	0.000395	CcSEcCtD
Indinavir—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	7.7e-05	0.000395	CcSEcCtD
Indinavir—Dizziness—Vincristine—peripheral nervous system neoplasm	7.69e-05	0.000394	CcSEcCtD
Indinavir—Vomiting—Alitretinoin—peripheral nervous system neoplasm	7.67e-05	0.000393	CcSEcCtD
Indinavir—Rash—Alitretinoin—peripheral nervous system neoplasm	7.61e-05	0.00039	CcSEcCtD
Indinavir—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	7.6e-05	0.000389	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	7.59e-05	0.000389	CcSEcCtD
Indinavir—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	7.57e-05	0.000388	CcSEcCtD
Indinavir—Headache—Alitretinoin—peripheral nervous system neoplasm	7.56e-05	0.000387	CcSEcCtD
Indinavir—Renal failure—Doxorubicin—peripheral nervous system neoplasm	7.53e-05	0.000386	CcSEcCtD
Indinavir—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	7.51e-05	0.000385	CcSEcCtD
Indinavir—Urticaria—Etoposide—peripheral nervous system neoplasm	7.48e-05	0.000383	CcSEcCtD
Indinavir—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	7.47e-05	0.000383	CcSEcCtD
Indinavir—Jaundice—Doxorubicin—peripheral nervous system neoplasm	7.46e-05	0.000383	CcSEcCtD
Indinavir—Abdominal pain—Etoposide—peripheral nervous system neoplasm	7.44e-05	0.000381	CcSEcCtD
Indinavir—Body temperature increased—Etoposide—peripheral nervous system neoplasm	7.44e-05	0.000381	CcSEcCtD
Indinavir—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	7.44e-05	0.000381	CcSEcCtD
Indinavir—Hepatitis—Epirubicin—peripheral nervous system neoplasm	7.43e-05	0.000381	CcSEcCtD
Indinavir—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	7.43e-05	0.000381	CcSEcCtD
Indinavir—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	7.39e-05	0.000379	CcSEcCtD
Indinavir—Vomiting—Vincristine—peripheral nervous system neoplasm	7.39e-05	0.000379	CcSEcCtD
Indinavir—Asthenia—Cisplatin—peripheral nervous system neoplasm	7.37e-05	0.000378	CcSEcCtD
Indinavir—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	7.37e-05	0.000378	CcSEcCtD
Indinavir—Sweating—Doxorubicin—peripheral nervous system neoplasm	7.34e-05	0.000376	CcSEcCtD
Indinavir—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	7.34e-05	0.000376	CcSEcCtD
Indinavir—Rash—Vincristine—peripheral nervous system neoplasm	7.33e-05	0.000376	CcSEcCtD
Indinavir—Dermatitis—Vincristine—peripheral nervous system neoplasm	7.32e-05	0.000375	CcSEcCtD
Indinavir—Haematuria—Doxorubicin—peripheral nervous system neoplasm	7.3e-05	0.000374	CcSEcCtD
Indinavir—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	7.3e-05	0.000374	CcSEcCtD
Indinavir—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	7.28e-05	0.000373	CcSEcCtD
Indinavir—Headache—Vincristine—peripheral nervous system neoplasm	7.28e-05	0.000373	CcSEcCtD
Indinavir—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	7.24e-05	0.000371	CcSEcCtD
Indinavir—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	7.18e-05	0.000368	CcSEcCtD
Indinavir—Nausea—Alitretinoin—peripheral nervous system neoplasm	7.16e-05	0.000367	CcSEcCtD
Indinavir—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	7.03e-05	0.00036	CcSEcCtD
Indinavir—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	7.02e-05	0.00036	CcSEcCtD
Indinavir—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	6.94e-05	0.000356	CcSEcCtD
Indinavir—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	6.91e-05	0.000354	CcSEcCtD
Indinavir—Nausea—Vincristine—peripheral nervous system neoplasm	6.9e-05	0.000354	CcSEcCtD
Indinavir—Flushing—Epirubicin—peripheral nervous system neoplasm	6.89e-05	0.000353	CcSEcCtD
Indinavir—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	6.87e-05	0.000352	CcSEcCtD
Indinavir—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	6.87e-05	0.000352	CcSEcCtD
Indinavir—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.000351	CcSEcCtD
Indinavir—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	6.82e-05	0.00035	CcSEcCtD
Indinavir—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	6.79e-05	0.000348	CcSEcCtD
Indinavir—Asthenia—Etoposide—peripheral nervous system neoplasm	6.76e-05	0.000346	CcSEcCtD
Indinavir—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	6.75e-05	0.000346	CcSEcCtD
Indinavir—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	6.74e-05	0.000345	CcSEcCtD
Indinavir—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	6.71e-05	0.000344	CcSEcCtD
Indinavir—Chills—Epirubicin—peripheral nervous system neoplasm	6.67e-05	0.000342	CcSEcCtD
Indinavir—Pruritus—Etoposide—peripheral nervous system neoplasm	6.66e-05	0.000341	CcSEcCtD
Indinavir—Alopecia—Epirubicin—peripheral nervous system neoplasm	6.56e-05	0.000336	CcSEcCtD
Indinavir—Vomiting—Cisplatin—peripheral nervous system neoplasm	6.53e-05	0.000335	CcSEcCtD
Indinavir—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	6.5e-05	0.000333	CcSEcCtD
Indinavir—Rash—Cisplatin—peripheral nervous system neoplasm	6.48e-05	0.000332	CcSEcCtD
Indinavir—Dermatitis—Cisplatin—peripheral nervous system neoplasm	6.47e-05	0.000332	CcSEcCtD
Indinavir—Malnutrition—Epirubicin—peripheral nervous system neoplasm	6.47e-05	0.000331	CcSEcCtD
Indinavir—Diarrhoea—Etoposide—peripheral nervous system neoplasm	6.44e-05	0.00033	CcSEcCtD
Indinavir—Flushing—Doxorubicin—peripheral nervous system neoplasm	6.38e-05	0.000327	CcSEcCtD
Indinavir—Flatulence—Epirubicin—peripheral nervous system neoplasm	6.37e-05	0.000327	CcSEcCtD
Indinavir—Tension—Epirubicin—peripheral nervous system neoplasm	6.35e-05	0.000325	CcSEcCtD
Indinavir—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	6.33e-05	0.000325	CcSEcCtD
Indinavir—Nervousness—Epirubicin—peripheral nervous system neoplasm	6.28e-05	0.000322	CcSEcCtD
Indinavir—Back pain—Epirubicin—peripheral nervous system neoplasm	6.26e-05	0.000321	CcSEcCtD
Indinavir—Dizziness—Etoposide—peripheral nervous system neoplasm	6.23e-05	0.000319	CcSEcCtD
Indinavir—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	6.22e-05	0.000319	CcSEcCtD
Indinavir—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	6.21e-05	0.000318	CcSEcCtD
Indinavir—Chills—Doxorubicin—peripheral nervous system neoplasm	6.17e-05	0.000316	CcSEcCtD
Indinavir—Nausea—Cisplatin—peripheral nervous system neoplasm	6.1e-05	0.000313	CcSEcCtD
Indinavir—Vision blurred—Epirubicin—peripheral nervous system neoplasm	6.09e-05	0.000312	CcSEcCtD
Indinavir—Alopecia—Doxorubicin—peripheral nervous system neoplasm	6.07e-05	0.000311	CcSEcCtD
Indinavir—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	6e-05	0.000308	CcSEcCtD
Indinavir—Vomiting—Etoposide—peripheral nervous system neoplasm	5.99e-05	0.000307	CcSEcCtD
Indinavir—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	5.98e-05	0.000307	CcSEcCtD
Indinavir—Anaemia—Epirubicin—peripheral nervous system neoplasm	5.98e-05	0.000306	CcSEcCtD
Indinavir—Agitation—Epirubicin—peripheral nervous system neoplasm	5.94e-05	0.000305	CcSEcCtD
Indinavir—Rash—Etoposide—peripheral nervous system neoplasm	5.94e-05	0.000304	CcSEcCtD
Indinavir—Dermatitis—Etoposide—peripheral nervous system neoplasm	5.93e-05	0.000304	CcSEcCtD
Indinavir—Headache—Etoposide—peripheral nervous system neoplasm	5.9e-05	0.000302	CcSEcCtD
Indinavir—Flatulence—Doxorubicin—peripheral nervous system neoplasm	5.9e-05	0.000302	CcSEcCtD
Indinavir—Tension—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	0.000301	CcSEcCtD
Indinavir—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	5.86e-05	0.0003	CcSEcCtD
Indinavir—Malaise—Epirubicin—peripheral nervous system neoplasm	5.83e-05	0.000299	CcSEcCtD
Indinavir—Nervousness—Doxorubicin—peripheral nervous system neoplasm	5.81e-05	0.000298	CcSEcCtD
Indinavir—Vertigo—Epirubicin—peripheral nervous system neoplasm	5.81e-05	0.000298	CcSEcCtD
Indinavir—Syncope—Epirubicin—peripheral nervous system neoplasm	5.8e-05	0.000297	CcSEcCtD
Indinavir—Back pain—Doxorubicin—peripheral nervous system neoplasm	5.79e-05	0.000297	CcSEcCtD
Indinavir—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	5.75e-05	0.000295	CcSEcCtD
Indinavir—Palpitations—Epirubicin—peripheral nervous system neoplasm	5.71e-05	0.000293	CcSEcCtD
Indinavir—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	5.68e-05	0.000291	CcSEcCtD
Indinavir—Cough—Epirubicin—peripheral nervous system neoplasm	5.64e-05	0.000289	CcSEcCtD
Indinavir—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	5.64e-05	0.000289	CcSEcCtD
Indinavir—Nausea—Etoposide—peripheral nervous system neoplasm	5.59e-05	0.000287	CcSEcCtD
Indinavir—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	5.55e-05	0.000285	CcSEcCtD
Indinavir—Anaemia—Doxorubicin—peripheral nervous system neoplasm	5.53e-05	0.000283	CcSEcCtD
Indinavir—Arthralgia—Epirubicin—peripheral nervous system neoplasm	5.51e-05	0.000282	CcSEcCtD
Indinavir—Chest pain—Epirubicin—peripheral nervous system neoplasm	5.51e-05	0.000282	CcSEcCtD
Indinavir—Myalgia—Epirubicin—peripheral nervous system neoplasm	5.51e-05	0.000282	CcSEcCtD
Indinavir—Agitation—Doxorubicin—peripheral nervous system neoplasm	5.5e-05	0.000282	CcSEcCtD
Indinavir—Anxiety—Epirubicin—peripheral nervous system neoplasm	5.49e-05	0.000281	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	5.47e-05	0.00028	CcSEcCtD
Indinavir—Discomfort—Epirubicin—peripheral nervous system neoplasm	5.44e-05	0.000279	CcSEcCtD
Indinavir—Malaise—Doxorubicin—peripheral nervous system neoplasm	5.4e-05	0.000277	CcSEcCtD
Indinavir—Dry mouth—Epirubicin—peripheral nervous system neoplasm	5.38e-05	0.000276	CcSEcCtD
Indinavir—Vertigo—Doxorubicin—peripheral nervous system neoplasm	5.38e-05	0.000276	CcSEcCtD
Indinavir—Syncope—Doxorubicin—peripheral nervous system neoplasm	5.37e-05	0.000275	CcSEcCtD
Indinavir—Palpitations—Doxorubicin—peripheral nervous system neoplasm	5.29e-05	0.000271	CcSEcCtD
Indinavir—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	5.28e-05	0.000271	CcSEcCtD
Indinavir—Oedema—Epirubicin—peripheral nervous system neoplasm	5.28e-05	0.000271	CcSEcCtD
Indinavir—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	5.26e-05	0.00027	CcSEcCtD
Indinavir—Cough—Doxorubicin—peripheral nervous system neoplasm	5.22e-05	0.000268	CcSEcCtD
Indinavir—Shock—Epirubicin—peripheral nervous system neoplasm	5.19e-05	0.000266	CcSEcCtD
Indinavir—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	5.18e-05	0.000265	CcSEcCtD
Indinavir—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	5.17e-05	0.000265	CcSEcCtD
Indinavir—Skin disorder—Epirubicin—peripheral nervous system neoplasm	5.13e-05	0.000263	CcSEcCtD
Indinavir—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	5.1e-05	0.000262	CcSEcCtD
Indinavir—Chest pain—Doxorubicin—peripheral nervous system neoplasm	5.09e-05	0.000261	CcSEcCtD
Indinavir—Myalgia—Doxorubicin—peripheral nervous system neoplasm	5.09e-05	0.000261	CcSEcCtD
Indinavir—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	5.09e-05	0.000261	CcSEcCtD
Indinavir—Anxiety—Doxorubicin—peripheral nervous system neoplasm	5.08e-05	0.00026	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	5.06e-05	0.000259	CcSEcCtD
Indinavir—Discomfort—Doxorubicin—peripheral nervous system neoplasm	5.03e-05	0.000258	CcSEcCtD
Indinavir—Anorexia—Epirubicin—peripheral nervous system neoplasm	5.03e-05	0.000258	CcSEcCtD
Indinavir—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	4.98e-05	0.000255	CcSEcCtD
Indinavir—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	4.88e-05	0.00025	CcSEcCtD
Indinavir—Oedema—Doxorubicin—peripheral nervous system neoplasm	4.88e-05	0.00025	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	4.81e-05	0.000246	CcSEcCtD
Indinavir—Shock—Doxorubicin—peripheral nervous system neoplasm	4.8e-05	0.000246	CcSEcCtD
Indinavir—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	4.79e-05	0.000245	CcSEcCtD
Indinavir—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	4.78e-05	0.000245	CcSEcCtD
Indinavir—Insomnia—Epirubicin—peripheral nervous system neoplasm	4.77e-05	0.000245	CcSEcCtD
Indinavir—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	4.74e-05	0.000243	CcSEcCtD
Indinavir—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	4.74e-05	0.000243	CcSEcCtD
Indinavir—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	4.72e-05	0.000242	CcSEcCtD
Indinavir—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	4.71e-05	0.000241	CcSEcCtD
Indinavir—Somnolence—Epirubicin—peripheral nervous system neoplasm	4.69e-05	0.00024	CcSEcCtD
Indinavir—Anorexia—Doxorubicin—peripheral nervous system neoplasm	4.65e-05	0.000239	CcSEcCtD
Indinavir—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	4.65e-05	0.000238	CcSEcCtD
Indinavir—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	4.59e-05	0.000235	CcSEcCtD
Indinavir—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.000234	CcSEcCtD
Indinavir—Fatigue—Epirubicin—peripheral nervous system neoplasm	4.55e-05	0.000233	CcSEcCtD
Indinavir—Constipation—Epirubicin—peripheral nervous system neoplasm	4.51e-05	0.000231	CcSEcCtD
Indinavir—Pain—Epirubicin—peripheral nervous system neoplasm	4.51e-05	0.000231	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	4.45e-05	0.000228	CcSEcCtD
Indinavir—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.42e-05	0.000226	CcSEcCtD
Indinavir—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	4.38e-05	0.000225	CcSEcCtD
Indinavir—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	4.35e-05	0.000223	CcSEcCtD
Indinavir—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	4.35e-05	0.000223	CcSEcCtD
Indinavir—Somnolence—Doxorubicin—peripheral nervous system neoplasm	4.34e-05	0.000223	CcSEcCtD
Indinavir—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	4.32e-05	0.000221	CcSEcCtD
Indinavir—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.3e-05	0.00022	CcSEcCtD
Indinavir—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4.25e-05	0.000218	CcSEcCtD
Indinavir—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000216	CcSEcCtD
Indinavir—Fatigue—Doxorubicin—peripheral nervous system neoplasm	4.21e-05	0.000216	CcSEcCtD
Indinavir—Urticaria—Epirubicin—peripheral nervous system neoplasm	4.19e-05	0.000215	CcSEcCtD
Indinavir—Constipation—Doxorubicin—peripheral nervous system neoplasm	4.18e-05	0.000214	CcSEcCtD
Indinavir—Pain—Doxorubicin—peripheral nervous system neoplasm	4.18e-05	0.000214	CcSEcCtD
Indinavir—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	4.17e-05	0.000214	CcSEcCtD
Indinavir—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	4.17e-05	0.000214	CcSEcCtD
Indinavir—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.02e-05	0.000206	CcSEcCtD
Indinavir—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	3.99e-05	0.000205	CcSEcCtD
Indinavir—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	3.89e-05	0.000199	CcSEcCtD
Indinavir—Urticaria—Doxorubicin—peripheral nervous system neoplasm	3.88e-05	0.000199	CcSEcCtD
Indinavir—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	3.86e-05	0.000198	CcSEcCtD
Indinavir—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	3.86e-05	0.000198	CcSEcCtD
Indinavir—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.79e-05	0.000194	CcSEcCtD
Indinavir—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.73e-05	0.000191	CcSEcCtD
Indinavir—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.61e-05	0.000185	CcSEcCtD
Indinavir—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.6e-05	0.000184	CcSEcCtD
Indinavir—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.5e-05	0.00018	CcSEcCtD
Indinavir—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.49e-05	0.000179	CcSEcCtD
Indinavir—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.45e-05	0.000177	CcSEcCtD
Indinavir—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.36e-05	0.000172	CcSEcCtD
Indinavir—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.34e-05	0.000171	CcSEcCtD
Indinavir—Rash—Epirubicin—peripheral nervous system neoplasm	3.33e-05	0.000171	CcSEcCtD
Indinavir—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.32e-05	0.00017	CcSEcCtD
Indinavir—Headache—Epirubicin—peripheral nervous system neoplasm	3.31e-05	0.000169	CcSEcCtD
Indinavir—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.23e-05	0.000166	CcSEcCtD
Indinavir—Nausea—Epirubicin—peripheral nervous system neoplasm	3.13e-05	0.000161	CcSEcCtD
Indinavir—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.1e-05	0.000159	CcSEcCtD
Indinavir—Rash—Doxorubicin—peripheral nervous system neoplasm	3.08e-05	0.000158	CcSEcCtD
Indinavir—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.08e-05	0.000158	CcSEcCtD
Indinavir—Headache—Doxorubicin—peripheral nervous system neoplasm	3.06e-05	0.000157	CcSEcCtD
Indinavir—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.9e-05	0.000149	CcSEcCtD
